F. Hoffmann-La Roche Ltd, Siemens Ag and Abbott are Dominating the Market for Global Cholesterol Testing Market in 2017

Global Cholesterol Testing Market is expected to reach USD 10,290.57 million by 2025 from USD 5,727.60 million in 2018, at a CAGR of 7.7% in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Global Cholesterol Testing MarketAccess Full Report: http://databridgemarketresearch.com/reports/global-cholesterol-testing-market/

The global cholesterol testing market is highly concentrated to a few big players and rest to local players who cater to domestic markets only. F. Hoffmann-La Roche Ltd dominated the cholesterol testing market accounting for a highest market share in 2017, followed by Siemens AG and Abbott Other players in this market include are Accutech, LLC, Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., Prima Lab SA, Quest Diagnostics, Inc., Home Access Health Corporation, and Sigma-Aldrich Corp. among others.


Established in 1896 and headquartered at Basel, Switzerland. F. Hoffmann-La Roche Ltd. is one of the largest biotech companies with 17 biopharmaceuticals on the market. Since the establishment in 1896, the company is focused into manufacturing of products for oncology, immunology, ophthalmology, infectious diseases and neuroscience. The company is operating in more than 100 countries around the globe. Some of the subsidiaries are Genetech, Roche Diagnostics, Chugai Pharmaceutical Co., Ventana Medical Systems, InterMune, Inc., Syntex, Anadys Pharmaceuticals, Roche Applied Science, Bioveris, Roche products, Inc., Roche pharma AG, Pt Roche Indonesia, Bina Technologies, Inc., NV Roche SA, Roche SAS, Roche Glycart AG, and Roche Co., Ltd.


Founded in 1847 and headquartered in Munich, Germany. Siemens is involved in the field of automation, electrification and digitalization. Siemens comprises Siemens AG, a stock corporation under the federal laws of the company and its subsidiaries. The company's operations spans across Europe, Commonwealth of Independent States (C.I.S), Africa, Middle East, Americas, Asia and Australia.

Siemens operates in eight business segments: power and gas, wind power and renewables, energy management, building technologies, mobility, digital factory and process industries and drives and healthineers.

Healthineers which was previously named as “Healthcare”, is one of the world’s largest suppliers of technology to the healthcare industry and a leader in medical imaging and laboratory diagnostics. Healthineers segment provides medical technology and software solutions as well as clinical consulting services, supported by a complete set of training and service offerings. The company offers medical solutions for prevention and early detection to diagnosis, treatment and follow-up care.


Abbott was incorporated in 1990 and headquartered in Illinois, U.S. It is a globally diversified healthcare company focused in discovery, development, manufacture, and marketing of broad line of health care products. It operates its business through four segments, established pharmaceutical products, diagnostic products, nutritional products, and vascular products.

Abbott operates in more than 150 countries across United States, Europe, Western Hemisphere, Africa, and Asia-Pacific. For instance, Abbott Administration Inc. (Delaware), Abbott Home Infusion Services, Inc. (New York), Abbott Laboratories International Co. (Illinois), Abbott Australasia Pty Ltd.(Australia), Murex Diagnostics International, Inc. (Barbados), Abbott S.A. (Belgium).